Echevarría J, Seas C, Carrillo C, Mostorino R, Ruiz R, Gotuzzo E
Instituto de Medicina Tropical, Alexander von Humboldt, Universidad Pertuana Cayetano Heredia, Lima, Peru.
Clin Infect Dis. 1995 Jun;20(6):1480-4. doi: 10.1093/clinids/20.6.1480.
We conducted a randomized double-blinded study in Lima, Peru, to assess the tolerability and efficacy of a single 250-mg dose of ciprofloxacin in preventing diarrhea and Vibrio cholerae O1 infection among household contacts of bacteriologically confirmed index cases. Adult household contacts with negative baseline stool cultures were included. A total of 213 household contacts were evaluable. The study drugs were well tolerated in both groups. Ciprofloxacin did not prevent the acquisition of V. cholerae O1 infection nor the development of diarrhea. However, in a subgroup of 30 household contacts with positive baseline stool cultures a reduction in the bacterial load and a trend toward prevention of diarrhea were observed among ciprofloxacin recipients. When all household contacts were evaluated, a trend toward prevention of diarrhea was observed with the prophylactic regimen. Ciprofloxacin failed to prevent V. cholerae O1 infections during a period of low transmissibility.
我们在秘鲁利马进行了一项随机双盲研究,以评估单剂量250毫克环丙沙星在预防细菌性确诊指数病例的家庭接触者腹泻和霍乱弧菌O1感染方面的耐受性和疗效。纳入基线粪便培养阴性的成年家庭接触者。共有213名家庭接触者可进行评估。两组对研究药物的耐受性均良好。环丙沙星未能预防霍乱弧菌O1感染的发生,也未能预防腹泻。然而,在30名基线粪便培养呈阳性的家庭接触者亚组中,环丙沙星接受者的细菌载量有所降低,且有预防腹泻的趋势。当评估所有家庭接触者时,预防性方案有预防腹泻的趋势。在传播率较低的时期,环丙沙星未能预防霍乱弧菌O1感染。